Executive Summary: Clinical Practice Guideline of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) in China

被引：21

作者：

Liu, Zhi-Hong ^{[1
]}

Li, Guisen ^{[2
,3
]}

Zhang, Ling ^{[4
]}

Chen, Jianghua ^{[5
]}

Chen, Xiaonong ^{[6
]}

Zhao, Jinghong ^{[7
]}

Liang, Xinling ^{[8
]}

机构：

[1] Nanjing Gen Hosp, Natl Clin Res Ctr Kidney Dis, Dept Nephrol, Nanjing 210002, Jiangsu, Peoples R China

[2] Univ Elect Sci, Sichuan Acad Med Sci, Sch Med, Chengdu, Sichuan, Peoples R China

[3] Univ Elect Sci, Sichuan Prov Peoples Hosp, Sch Med, Chengdu, Sichuan, Peoples R China

[4] Sino Japanese Friendship Hosp, Dept Nephrol, Beijing, Peoples R China

[5] Zhejiang Univ, Affiliated Hosp 1, Dept Nephrol, Sch Med, Hangzhou, Zhejiang, Peoples R China

[6] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Nephrol, Sch Med, Shanghai, Peoples R China

[7] Third Mil Med Univ, Dept Nephrol, Chongqing, Peoples R China

[8] Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China

来源：

KIDNEY DISEASES | 2019年 / 5卷 / 04期

关键词：

Chronic kidney disease; Mineral and bone disorder; Guideline; China;

D O I：

10.1159/000500053

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Chronic kidney disease (CKD) is a global health concern. The prevalence of CKD in Chinese adults is over 10%. Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the complications of CKD, which may cause many serious adverse outcomes such as disability and death in CKD patients. In recent years, a series of guidelines for the diagnosis and treatment of CKD-MBD have been developed by several international organizations for kidney disease. In 2013, the working group developed the Guidance for Diagnosis and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder, which greatly promoted clinical management and researches of CKD-MBD in China. In the past five years, Chinese clinicians have been deepening their understanding and standardized management of CKD-MBD and implemented a large number of clinical and basic researches on CKD-MBD. In combination with international research results, the working group updated the guidelines. This guideline includes five chapters: introduction and definition of CKD-MBD; diagnosis of CKD-MBD; prevention and treatment of CKD-MBD; prevention and treatment of osteoporosis in patients with CKD; and evaluation and treatment of CKD-MBD in kidney transplant recipients; and five appendixes. In this summary, we highlight the main recommendations and suggestions of the guideline. (C) 2019 S. Karger AG, Basel

引用

页码：197 / 203

页数：7